Zimmer biomet outlines strategy to deliver above market growth at 2024 investor day

Presents path for compelling and durable topline growth, improved operational profitability and increased free cash flow generation details new capital allocation priorities and commitment to strategic diversification announces strategic partnership with cbre, the world's largest commercial real estate services and investment firm, to develop and outfit orthopedic ambulatory surgery centers (asc) in the u.s. warsaw, ind. and new york , may 29, 2024 /prnewswire/ -- zimmer biomet holdings, inc. (nyse and six: zbh), a global medical technology leader, today hosted its 2024 investor day and provided an in-depth review of the company's strategic priorities and long-range plan for growth and value creation.
CBRE Ratings Summary
CBRE Quant Ranking